Show simple item record

dc.contributor.authorKasali, Félicien Mushagalusa
dc.contributor.authorTusiimire, Jonans
dc.contributor.authorKadima, Justin Ntokamunda
dc.contributor.authorAgaba, Amon Ganafa
dc.date.accessioned2022-01-31T12:20:54Z
dc.date.available2022-01-31T12:20:54Z
dc.date.issued2021
dc.identifier.citationKasali, F. M., Tusiimire, J., Kadima, J. N., & Agaba, A. G. (2021). Ethnomedical uses, chemical constituents, and evidence-based pharmacological properties of Chenopodium ambrosioides L.: extensive overview. Future Journal of Pharmaceutical Sciences, 7(1), 1-36.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/1315
dc.description.abstractBackground: The Chenopodium genus is a plant family widely spread worldwide that includes various plant species reputed to possess several medicinal virtues in folk medicines. Chenopodium ambrosioides L. is among the most used plants in traditional medicines worldwide. This review aimed to highlight ethnomedicinal uses, phytochemical status, and pharmacological properties of C. ambrosioides L. Main body of the abstract: The analysis of relevant data highlights various ethnomedicinal uses against human and veterinary diseases in forty countries. Most indications consisted of gastrointestinal tract dysfunctioning troubles and worms parasitemia. Around 330 chemical compounds have been identified in different plant parts, especially in its essential oil fractions (59.84%). However, only a few compounds—mainly monoterpenes and glycosides—have been isolated and characterized. Experimental pharmacological studies validated a large scale of significant health benefits. It appeared that many monoterpenes are antioxidant, insecticidal, trypanocidal, analgesic, antifungal, antiinflammatory, anti-arthritic, acaricidal, amoebicidal, anthelmintic, anticancer, antibacterial, antidiabetic, antidiarrheal, antifertility, and antifungal, anti-leishmanial, antimalarial, antipyretic, antisickling, antischistosomal, antiulcer, anxiolytic, immunomodulatory, molluscicidal, and vasorelaxant agents. Short conclusion: Thus, the Chenopodium ambrosioides species necessitates further chemical studies to isolate and characterize new bioactive secondary metabolites and pharmacological investigations to precise the mechanisms of action before clinical trialen_US
dc.language.isoen_USen_US
dc.publisherFuture Journal of Pharmaceutical Sciencesen_US
dc.subjectChenopodium ambrosioidesen_US
dc.subjectBioactive compounden_US
dc.subjectTherapeutic indicationsen_US
dc.subjectPharmacological bioactivityen_US
dc.titleEthnomedical uses, chemical constituents, and evidence-based pharmacological properties of Chenopodium ambrosioides L.: extensive overviewen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record